COM:HYLORIS
Hyloris Pharmaceuticals
- Stock
Last Close
5.80
22/11 16:35
Market Cap
327.60M
Beta: -
Volume Today
60.81K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 498.50K - | 498.50K 0% | -234.50K - | ||||||
average payables | 1.37M - | 1.91M 39.33% | 2.46M 28.65% | 2.23M 9.37% | 2.11M 5.47% | 2.46M 16.77% | 2.90M 17.75% | ||
average receivables | 93K - | 170K 82.80% | 77K 54.71% | 4.61M - | |||||
book value per share | -0.18 - | -0.10 47.60% | -0.43 353.61% | 2.71 725.73% | 1.86 31.27% | 2.02 8.79% | |||
capex per share | -0.12 - | -0.00 98.89% | -0.05 3,867.74% | -0.03 45.33% | -0.04 43.84% | -0.03 33.85% | |||
capex to depreciation | -43.08 - | -0.35 99.18% | -0.37 5.61% | -1.07 188.21% | -7.74 622.24% | -3.77 51.32% | -2.07 45.06% | ||
capex to operating cash flow | 1.73 - | 0.01 99.67% | 0.27 4,568.75% | 0.14 49.44% | 0.09 30.82% | 0.06 40.43% | 0.06 4.43% | ||
capex to revenue | -13.15 - | -0.34 97.41% | -13.52 3,867.74% | -3.56 73.66% | -0.34 90.37% | -0.25 26.93% | -0.26 2.60% | ||
cash per share | 0.01 - | 0.11 856.23% | 0.01 92.37% | 2.95 33,812.89% | 1.96 33.72% | 1.61 17.45% | |||
days of inventory on hand | 5.60K - | 0.00 - | |||||||
days payables outstanding | 6.80K - | 11.55K 69.77% | 15.85K 37.28% | 4.01K 74.67% | 8.94K 122.77% | 8.94K 0.06% | 2.89K 67.70% | ||
days sales outstanding | 318.73 - | 617.69 93.80% | 531.81 - | ||||||
debt to assets | 1.85 - | 1.56 15.91% | 1.18 24.41% | 2.21 87.27% | 0.12 94.46% | 0.19 58.66% | 0.01 92.61% | 0.11 677.40% | |
debt to equity | -1.14 - | -1.59 39.32% | -4.17 162.66% | -1.30 68.92% | 0.14 111.04% | 0.26 78.81% | 0.02 93.71% | 0.14 748.33% | |
dividend yield | |||||||||
earnings yield | -0.02 - | -0.02 55.80% | -0.02 0.40% | -0.03 46.26% | -0.03 24.85% | -0.03 31.75% | |||
enterprise value | 2.27M - | 251.23M 10,977.29% | 251.38M 0.06% | 257.69M 2.51% | 151.33M 41.28% | 409.18M 170.40% | 272.94M 33.30% | -24.90M 109.12% | |
enterprise value over ebitda | -70.33 - | -44.64 36.53% | -124.79 179.54% | -26.67 78.63% | -38.64 44.89% | -26.69 30.92% | 1.44 105.38% | ||
ev to operating cash flow | -155.47 - | -46.83 69.88% | -56.49 20.62% | -33.11 41.38% | -36.37 9.84% | -20.75 42.95% | 2.02 109.74% | ||
ev to sales | 1.18K - | 2.76K 134.20% | 2.83K 2.51% | 864.72 69.46% | 132.16 84.72% | 92.49 30.02% | -8.85 109.57% | ||
free cash flow per share | -0.19 - | -0.23 22.26% | -0.25 7.28% | -0.24 3.22% | -0.48 100.23% | -0.51 7.18% | |||
free cash flow yield | -0.02 - | -0.02 22.26% | -0.02 7.28% | -0.03 5.85% | -0.03 9.96% | -0.04 59.85% | |||
graham net net | -0.35 - | -0.39 10.67% | -0.68 75.28% | 2.49 466.99% | 1.36 45.30% | 1.36 0.26% | |||
graham number | 0.80 - | 0.73 9.64% | 1.54 112.56% | 4.47 189.27% | 4.33 3.02% | 4.25 1.97% | |||
income quality | 0.42 - | 0.98 134.81% | 0.86 11.87% | 0.64 26.06% | 0.97 51.90% | 1.22 25.71% | 0.78 35.99% | ||
intangibles to total assets | 0.74 - | 0.88 17.74% | 0.50 43.30% | 0.36 28.08% | 0.03 90.37% | 0.05 34.83% | 0.06 25.65% | 0 100% | |
interest coverage | -26.48 - | -16.09 39.25% | -12.83 20.22% | -5.62 56.19% | -18.61 231.05% | -47.98 157.81% | -44.99 6.24% | ||
interest debt per share | 0.29 - | 0.41 39.64% | 0.58 40.26% | 0.43 25.13% | 0.50 14.95% | 0.04 91.84% | |||
inventory turnover | 0.07 - | 442K - | |||||||
invested capital | -1.14 - | -1.59 39.32% | -4.17 162.66% | -1.30 68.92% | 0.14 111.04% | 0.26 78.81% | 0.02 93.71% | 0.14 748.33% | |
market cap | 244.70M - | 244.70M 0% | 244.70M 0% | 207.28M 15.29% | 446.90M 115.61% | 315.51M 29.40% | |||
net current asset value | -3.25M - | -8.15M 150.89% | -8.57M 5.20% | -12.43M 45.01% | 56.49M 554.39% | 38.57M 31.72% | 43.98M 14.03% | 26.48M 39.78% | |
net debt to ebitda | -1.83 - | -1.19 35.17% | -6.29 430.79% | 9.86 256.75% | 3.56 63.87% | 4.16 16.87% | 1.44 65.49% | ||
net income per share | -0.16 - | -0.25 55.80% | -0.24 0.40% | -0.33 33.73% | -0.45 36.86% | -0.40 11.66% | |||
operating cash flow per share | -0.07 - | -0.23 232.18% | -0.19 15.01% | -0.21 8.13% | -0.44 107.92% | -0.48 11.05% | |||
payables turnover | 0.05 - | 0.03 41.10% | 0.02 27.16% | 0.09 294.77% | 0.04 55.11% | 0.04 0.06% | 0.13 209.62% | ||
receivables turnover | 1.15 - | 0.59 48.40% | 0.69 - | ||||||
research and ddevelopement to revenue | 10.86 - | 53.52 392.82% | 50.30 6.02% | 19.50 61.22% | 1.63 91.63% | 3.44 110.64% | 5.24 52.37% | ||
return on tangible assets | -6.88 - | -1.45 78.96% | -1.50 3.59% | -0.11 92.87% | -0.19 78.91% | -0.18 3.41% | -0.33 79.07% | ||
revenue per share | 0.01 - | 0.00 57.28% | 0.00 0% | 0.01 107.58% | 0.12 1,394.26% | 0.11 9.47% | |||
roe | 0.87 - | 2.58 197.31% | 0.57 78.04% | -0.12 121.37% | -0.24 99.13% | -0.20 18.80% | -0.41 107.51% | ||
roic | -1.49 - | -0.75 49.41% | -1.71 127.11% | -0.08 95.18% | -0.18 112.86% | -0.19 5.43% | -0.40 118.65% | ||
sales general and administrative to revenue | 7.78 - | 6.84 12.14% | 8.88 29.90% | 12.54 41.20% | 0.94 92.53% | 1.19 27.23% | |||
shareholders equity per share | -0.18 - | -0.10 47.60% | -0.43 353.61% | 2.71 725.73% | 1.86 31.27% | 2.02 8.79% | |||
stock based compensation to revenue | 6.24 - | 2.77 - | 0.19 93.29% | 0.19 2.00% | |||||
tangible asset value | -3.19M - | -8.11M 154.34% | -8.41M 3.70% | -12.33M 46.55% | 56.68M 559.82% | 45.11M 20.41% | 51.44M 14.02% | 38.82M 24.53% | |
tangible book value per share | -0.34 - | -0.36 3.70% | -0.52 46.55% | 2.60 596.35% | 1.75 32.77% | 1.89 8.30% | |||
working capital | -777K - | -1.37M 76.06% | 736K 153.80% | -12.41M 1,786.14% | 64.48M 619.59% | 38.98M 39.55% | 45.03M 15.52% | 28.34M 37.07% |
All numbers in (except ratios and percentages)